ClinicalTrials.gg
Sign In
CompletedNCT07512388Updated Aug 19, 2026

Acceptance and Commitment Therapy for Post-Stroke Adjustment Via Telerehabilitation

An interventional study of Acceptance and Commitment Therapy in Stroke, Psychological Flexibility and Acceptance and Commitment Therapy, sponsored by University of East Anglia. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by University of East Anglia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Sep 2025, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

A stroke can affect someone physically and emotionally. There are more than 1.3 million stroke survivors in the UK, so it is important the right support is available.

Acceptance and commitment therapy is a psychological therapy that helps people adjust to new circumstances. Studies have found that it is helpful for people with long-term health conditions such as brain injury, chronic pain, and multiple sclerosis. Therefore, we want to assess if this therapy can help people adjust to life after a stroke.

To assess this, we are looking for adults over 18 who have:

  • Had a stroke over three months ago.
  • No other neurological illness.
  • No severe cognitive or communication difficulties.
  • Been discharged from all rehabilitation programmes.
  • No severe psychological disorder.
  • Not been diagnosed with a major health condition in the last 12 months.
  • Access to a device with a camera, an internet connection and private space for video calls.

Participants will:

  1. Complete a weekly questionnaire for up to seven weeks on acceptance and action.
  2. Complete a second questionnaire at week 7 on mood, what is important to participants and how the stroke has affected their life.
  3. Attend an eight-week online group of acceptance and commitment therapy. Sessions are weekly for 90 minutes, including breaks. Participants will repeat the questionnaire.
  4. Give feedback after therapy ends and repeat the questionnaires.
  5. Repeat the questionnaires after three and six months. Participants will be reminded to complete the online questionnaires and can take breaks as needed.

At the end of the study, participants will have a debrief call to discuss details of the study.

Participants will get a £10 Amazon gift card to thank them for taking part.

02

Conditions studied

  • Stroke
  • Psychological Flexibility
  • Acceptance and Commitment Therapy

Browse trials for

Keywords

  • Stroke
  • acceptance and commitment therapy
  • ACT
  • psychological flexibility
  • wellbeing
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 5 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of East Anglia is the lead sponsor of 79 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Suffered a stroke over three months ago.
  • No other neurological illness.
  • Not currently receiving any psychological intervention.
  • No severe communication difficulties.
  • No severe cognitive impairments.
  • No current or historical suicidal ideation/self-harming behaviours.
  • Not been diagnosed with major long-term health conditions in the last 12 months (except for stroke or trans-ischaemic attack; )
  • Access to a device with a camera, stable internet connection and private space

Exclusion criteria

Exclusion Criteria:

  • Had a without the presence of a stroke.
  • No current distress around adjusting to the consequences of stroke.
  • Distress of a severity that it cannot be managed safely in a group therapy setting.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Acceptance and Commitment Therapy

    8-week ACT group intervention.

    Other: Acceptance and Commitment Therapy

Interventions

  • OtherAcceptance and Commitment Therapy

    8 weeks of Acceptance and Commitment Therapy delivered as a group intervention via telerehabilitation (online, video call).

    Also known as: ACT

06

What researchers measure

Primary outcomes

  1. Psychological flexibility (CompACT-10)

    Data collected using self-report measure (CompACT-10). Questionnaire completed online, via a link. Data collected weekly during baseline phase (up to 7 weeks) and intervention phase (8 weeks).

    Time frame: From baseline to end of intervention (13-15 weeks dependent on baseline length allocated).

  2. Psychological Flexibility (CompACT-10)

    Data collected using self-report measure (CompACT-10). Questionnaire completed online, via a link. Data collected 6 months after intervention ends.

    Time frame: 6 months post-intervention.

Secondary outcomes

  1. Psychological Flexibility (CompACT-10)

    Data collected using self-report measure (CompACT-10). Questionnaire completed online, via a link. Data collected 3 months after intervention ends.

    Time frame: 3 months post-intervention.

  2. Psychological Distress (CORE-10)

    Data collected using self-report measure (CORE-10). Questionnaire completed online, via a link. Data collected immediately before and after intervention.

    Time frame: Start of intervention and 8 weeks later (after intervention ends)

  3. Psychological Distress (CORE-10)

    Data collected using self-report measure (CORE-10). Questionnaire completed online, via a link. Data collected 3 months after intervention ends.

    Time frame: 3 months post-intervention

  4. Psychological Distress (CORE-10)

    Data collected using self-report measure (CORE-10). Questionnaire completed online, via a link. Data collected 6 months after intervention ends.

    Time frame: 6 months post-intervention

  5. Stroke Specific Quality of Life (SSQoL-12)

    Data collected using self-report measure (SSQoL-12). Questionnaire completed online, via a link. Data collected immediately before and after 8 week intervention.

    Time frame: Start of intervention and post 8-week intervention.

  6. Stroke Specific Quality of Life (SSQoL-12)

    Data collected using self-report measure (SSQoL-12). Questionnaire completed online, via a link. Data collected 3 months post-intervention.

    Time frame: 3 months post-intervention

  7. Stroke Specific Quality of Life (SSQoL-12)

    Data collected using self-report measure (SSQoL-12). Questionnaire completed online, via a link. Data collected 6 months post-intervention.

    Time frame: 6 months post-intervention

  8. Independence/Participation (CIQ-15)

    Data collected using self-report measure (CIQ-15). Questionnaire completed online, via a link. Data collected 3 months post-intervention.

    Time frame: 3 months post-intervention

  9. Independence/Participation (CIQ-15)

    Data collected using self-report measure (CIQ-15). Questionnaire completed online, via a link. Data collected 6 months post-intervention.

    Time frame: 6 months post-intervention

  10. Independence/Participation (CIQ-15)

    Data collected using self-report measure (CIQ-15). Questionnaire completed online, via a link. Data collected immediately before and after 8 week intervention.

    Time frame: 8 weeks (before and after intervention).

  11. Wellbeing (SWEMWBS)

    Data collected using self-report measure (SWEMWBS). Questionnaire completed online, via a link. Data collected 3 months post-intervention.

    Time frame: 3 months post-intervention

  12. Wellbeing (SWEMWBS)

    Data collected using self-report measure (SWEMWBS). Questionnaire completed online, via a link. Data collected 6 months post-intervention.

    Time frame: 6 months post-intervention

  13. Wellbeing (SWEMWBS)

    Data collected using self-report measure (SWEMWBS). Questionnaire completed online, via a link. Data collected immediately before and after 8 week intervention.

    Time frame: 8 weeks (before and after intervention)

07

Study locations

1 site
  • University of East Anglia
    Norwich, United Kingdom
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Jun 2026, 9 months.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2026
First posted
Apr 6, 2026
StartActual
Sep 4, 2025
Primary completionActual
Jun 22, 2026
CompletionActual
Jun 22, 2026
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07512388
Lead sponsor
University of East Anglia
Responsible party
Sponsor
First posted
Apr 6, 2026
Start date
Sep 4, 2025
Primary completion
Jun 22, 2026
Completion
Jun 22, 2026
Last update
Aug 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stroke →

Other studies from this sponsor

University of East Anglia

Start the discussion